NO983234L - Ny medisinsk anvendelse av en ACE-inhibitor for behandling av dyspeptiske symptomer - Google Patents

Ny medisinsk anvendelse av en ACE-inhibitor for behandling av dyspeptiske symptomer

Info

Publication number
NO983234L
NO983234L NO983234A NO983234A NO983234L NO 983234 L NO983234 L NO 983234L NO 983234 A NO983234 A NO 983234A NO 983234 A NO983234 A NO 983234A NO 983234 L NO983234 L NO 983234L
Authority
NO
Norway
Prior art keywords
treatment
medical use
pct
ace inhibitor
new medical
Prior art date
Application number
NO983234A
Other languages
English (en)
Norwegian (no)
Other versions
NO983234D0 (no
Inventor
Lars Faendriks
Anders Petterson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO983234D0 publication Critical patent/NO983234D0/no
Publication of NO983234L publication Critical patent/NO983234L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/062—Copolymers with monomers not covered by C09J133/06
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/08—Homopolymers or copolymers of acrylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00795—Plasters special helping devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00846—Plasters with transparent or translucent part
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/28—Non-macromolecular organic substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO983234A 1996-01-15 1998-07-14 Ny medisinsk anvendelse av en ACE-inhibitor for behandling av dyspeptiske symptomer NO983234L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600120A SE9600120D0 (sv) 1996-01-15 1996-01-15 Novel medical use
PCT/SE1996/001733 WO1997026014A1 (en) 1996-01-15 1996-12-20 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms

Publications (2)

Publication Number Publication Date
NO983234D0 NO983234D0 (no) 1998-07-14
NO983234L true NO983234L (no) 1998-07-14

Family

ID=20401013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983234A NO983234L (no) 1996-01-15 1998-07-14 Ny medisinsk anvendelse av en ACE-inhibitor for behandling av dyspeptiske symptomer

Country Status (33)

Country Link
US (1) US5977159A (ja)
EP (1) EP0876158B1 (ja)
JP (1) JP2001501908A (ja)
KR (1) KR19990076973A (ja)
CN (1) CN1090031C (ja)
AT (1) ATE218885T1 (ja)
AU (1) AU710846B2 (ja)
BR (1) BR9612483A (ja)
CA (1) CA2240199A1 (ja)
CZ (1) CZ222398A3 (ja)
DE (1) DE69621834T2 (ja)
DK (1) DK0876158T3 (ja)
EE (1) EE03517B1 (ja)
ES (1) ES2175182T3 (ja)
HK (1) HK1014870A1 (ja)
HU (1) HUP9901353A3 (ja)
ID (1) ID16186A (ja)
IL (1) IL125195A (ja)
IS (1) IS4778A (ja)
MX (1) MX9805506A (ja)
MY (1) MY129782A (ja)
NO (1) NO983234L (ja)
NZ (1) NZ325973A (ja)
PL (1) PL327818A1 (ja)
PT (1) PT876158E (ja)
RU (1) RU2203092C2 (ja)
SE (1) SE9600120D0 (ja)
SI (1) SI0876158T1 (ja)
SK (1) SK282781B6 (ja)
TR (1) TR199801298T2 (ja)
UA (1) UA49861C2 (ja)
WO (1) WO1997026014A1 (ja)
ZA (1) ZA9783B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2340206A1 (en) * 1998-08-26 2000-03-09 Queen's University At Kingston Use of anti-pressor agents for vascular remodeling in genital dysfunction
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
AU2002308522A1 (en) * 2001-05-01 2002-11-11 University Of Southern California Methods for inhibiting tumor cell proliferation
WO2003075842A2 (en) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
US20050271657A1 (en) * 2004-06-08 2005-12-08 Australian Stem Cell Centre Ltd. Intermittent treatment regime for organ failure
US7776831B2 (en) 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20090227507A1 (en) * 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof
WO2010022249A2 (en) * 2008-08-20 2010-02-25 Ensemble Discovery Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
WO2010110439A1 (ja) * 2009-03-27 2010-09-30 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension

Also Published As

Publication number Publication date
CN1207685A (zh) 1999-02-10
CN1090031C (zh) 2002-09-04
ZA9783B (en) 1997-07-15
ATE218885T1 (de) 2002-06-15
PT876158E (pt) 2002-10-31
AU710846B2 (en) 1999-09-30
RU2203092C2 (ru) 2003-04-27
JP2001501908A (ja) 2001-02-13
DE69621834D1 (de) 2002-07-18
HK1014870A1 (en) 1999-10-08
EE9800203A (et) 1998-12-15
HUP9901353A3 (en) 2000-05-29
EP0876158A1 (en) 1998-11-11
IL125195A0 (en) 1999-03-12
DE69621834T2 (de) 2003-03-06
PL327818A1 (en) 1999-01-04
US5977159A (en) 1999-11-02
SK87998A3 (en) 1998-12-02
CA2240199A1 (en) 1997-07-24
IS4778A (is) 1998-06-19
HUP9901353A2 (hu) 1999-08-30
CZ222398A3 (cs) 1998-11-11
NO983234D0 (no) 1998-07-14
EP0876158B1 (en) 2002-06-12
KR19990076973A (ko) 1999-10-25
ES2175182T3 (es) 2002-11-16
UA49861C2 (uk) 2002-10-15
MY129782A (en) 2007-04-30
NZ325973A (en) 2001-05-25
TR199801298T2 (xx) 1998-10-21
WO1997026014A1 (en) 1997-07-24
BR9612483A (pt) 1999-07-13
SE9600120D0 (sv) 1996-01-15
MX9805506A (es) 1998-11-30
EE03517B1 (et) 2001-10-15
SI0876158T1 (en) 2002-12-31
DK0876158T3 (da) 2002-08-19
ID16186A (id) 1997-09-11
IL125195A (en) 2001-11-25
SK282781B6 (sk) 2002-12-03
AU1323797A (en) 1997-08-11

Similar Documents

Publication Publication Date Title
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
NO983234D0 (no) Ny medisinsk anvendelse av en ACE-inhibitor for behandling av dyspeptiske symptomer
SE9500422D0 (sv) New oral pharmaceutical dosage forms
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
DK0840607T3 (da) Ny medicinsk anvendelse
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
NO985558L (no) Ny forbedret formulering for behandling av tromboembolisme
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
UA38590A (uk) Спосіб лікування гломерулонефриту з анефротичним синдромом та гематуричним компонентом
NO976042D0 (no) Peptid som inhiberer ökning av triglycerid-nivå i blod, og inhibitor av ökning av triglyceridnivå i blod inneholdende nevnte peptid som aktiv bestanddel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application